This study was carried out to evaluate the reproductive performance and calves survival rate of Holstein-Friesian (HF) herd in Holeta, central highland of Ethiopia. A retrospective analysis of 26 years data was carried out, from which records of 724 age at first calving (AFC), 2,022 calving intervals (CI), 2,971 breeding efficiencies (BE), 260 abortions, 111 stillbirths were derived from 795 cows. Moreover, 738 female calves' records were also included for survival rate study. The overall least squares means of AFC, CI, and BE were 40.9 ± 0.33 months, 475 ± 2.84 days, 81.9 ± 0.26%, respectively, while the incidence rates of abortion, stillbirth, and female calves survival rate for this herd were 8.0%, 3.4%, and 77.5%, respectively. The effects of parity number and year of birth/calving on CI and BE were significant (P < 0.001). Moreover, birth year had significant (P < 0.001) effect on AFC and calves survival rate, while calving season had significant effect on BE. The reproductive performance found in this study was lower than the performance reported in many tropical regions and the genetic potential of HF breed in their origins. Moreover, higher loss due to calf mortality was observed. Thus, the centre should consider appropriate measures to improve its herd reproductive performance and calves survival rate for attaining its aspired objectives.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11250-010-9697-9 | DOI Listing |
Viruses
December 2024
Gilead Sciences, Inc., Foster City, CA 94404, USA.
Ebola virus (EBOV) causes severe disease in humans, with mortality as high as 90%. The small-molecule antiviral drug remdesivir (RDV) has demonstrated a survival benefit in EBOV-exposed rhesus macaques. Here, we characterize the efficacy of multiple intravenous RDV dosing regimens on survival of rhesus macaques 42 days after intramuscular EBOV exposure.
View Article and Find Full Text PDFViruses
November 2024
C.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
SARS-CoV-2 infection induces a humoral immune response, producing virus-specific antibodies such as IgM, IgG, and IgA. IgA antibodies are present at mucosal sites, protecting against respiratory and other mucosal infections, including SARS-CoV-2, by neutralizing viruses or impeding attachment to epithelial cells. Since SARS-CoV-2 spreads through the nasopharynx, the specific IgAs of SARS-CoV-2 are produced quickly after infection, effectively contributing to virus neutralization.
View Article and Find Full Text PDFViruses
November 2024
Department of Surgery, Campus Virchow Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Introduction: The development of chronic kidney disease (CKD) is a common and significant complication, contributing to morbidity after liver transplantation (LT). Cytomegalovirus (CMV) infection is common in the overall population, and relevant reinfection after LT may occur. CMV-associated kidney damage has been discussed, but the clinical significance on CKD development after LT remains unclear.
View Article and Find Full Text PDFSensors (Basel)
December 2024
Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada.
Ovarian cancer (OC) must be detected in its early stages when the mortality rate is the lowest to provide patients with the best chance of survival. Lysophosphatidic acid (LPA) is a critical OC biomarker since its levels are elevated across all stages and increase with disease progression. This paper presents an LPA assay based on a thickness shear mode acoustic sensor with dissipation monitoring that involves a new thiol molecule 3-(2-mercaptoethanoxy)propanoic acid (HS-MEG-COOH).
View Article and Find Full Text PDFPharmaceutics
December 2024
Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830046, China.
Background: The clinical efficacies of anticancer drugs are limited by non-selective toxic effects on healthy tissues and low bioavailability in tumor tissue. Therefore, the development of vehicles that can selectively deliver and release drugs at the tumor site is critical for further improvements in patient survival.
Methods: We prepared a CEC nano-drug delivery system, CEC@ZIF-8, with a zeolite imidazole framework-8 (ZIF-8) as a carrier, which can achieve the response of folate receptor (FR).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!